The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among US doctors, who said the recent withdrawal of an influential COVID-19 study left them wanting to see more data.
Global pressure to find a cure or vaccine has accelerated the process of reporting coronavirus study results, feeding confusion over whether therapies have been proven effective. One influential COVID-19 study was withdrawn this month by respected British medical journal The Lancet over data concerns.
Read the latest updates in our dedicated coronavirus section.
Trial results announced on Tuesday showed dexamethasone, used to fight inflammation in other diseases, reduced death rates by around a third among the most severely ill COVID-19 patients admitted to hospital. British scientists announced the results and said they would work to publish full details as soon as possible.
“We have been burned before, not just during the coronavirus pandemic but even pre-COVID, with exciting results that when we have access to the data are not as convincing,” said Dr. Kathryn Hibbert, director of the medical intensive care unit at Harvard’s Massachusetts General Hospital.
Hibbert said published data would help her evaluate the findings and see which patients benefited the most and at what dose.
“I am very hopeful this is true because it would be a huge step forward in being able to help our patients,” she said, but added she would not change practice at this point.
Steroids can suppress immune systems, warned Dr. Thomas McGinn, deputy physician-in-chief at New York’s largest healthcare system, Northwell Health where, he told Reuters, physicians are using steroids on a case-by-case basis.
“We have to see what the study looks like given the current environment of retractions,” said McGinn. “I just wait to see the real data, see if it’s peer reviewed and gets published in a real journal, he said.
University of Washington professor of medicine Dr Mark Wurfel urged the researchers to put out data before official publication.
“That would be very, very helpful in terms of helping us align our patient populations with theirs and decide whether it’s appropriate to apply this therapy to our patients.”
Coronavirus: Not all infected with COVID-19 test positive for antibodies, study saysNot all patients that have been infected with the coronavirus test positive for antibodies, raising questions as to the effectiveness of tests used to ... Coronavirus
Coronavirus: Authors retract hydroxychloroquine study that raised safety fearsThree of the authors of an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients retracted the study on ... World News
French doctor Didier Raoult defiant on hydroxychloroquine despite studyA controversial French doctor on Monday insisted he stood by his belief that anti-viral drugs hydroxychloroquine and chloroquine can help patients ... Coronavirus